{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:49:44Z","timestamp":1791078584875,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s00415-006-0198-8","type":"journal-article","created":{"date-parts":[[2006,9,23]],"date-time":"2006-09-23T02:38:25Z","timestamp":1158979105000},"page":"1137-1142","source":"Crossref","is-referenced-by-count":27,"title":["Apoptotic cascades as possible targets for inhibiting cell death in Huntington\u2019s disease"],"prefix":"10.1007","volume":"253","author":[{"given":"Lindsay R.","family":"Pattison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Kotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael M.","family":"Bonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,22]]},"reference":[{"key":"198_CR1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/hmg\/4.2.207","volume":"4","author":"E Almqvist","year":"1995","unstructured":"Almqvist E, Spence N, Nichol K, Andrew SE, Vesa J, Peltonen L, et al. (1995) Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington\u2019s disease. Hum Mol Genet 4:207\u2013214","journal-title":"Hum Mol Genet"},{"key":"198_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/1570160043377475","volume":"2","author":"L Arregui","year":"2004","unstructured":"Arregui L, Segovia J (2004) Molecular Strategies for the Treatment of Huntington\u2019s Disease. Curr Pharmacogenom 2:299\u2013311","journal-title":"Curr Pharmacogenom"},{"key":"198_CR3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00004647-199908000-00001","volume":"19","author":"FC Barone","year":"1999","unstructured":"Barone FC, Feuerstein GZ (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19:819\u2013834","journal-title":"J Cereb Blood Flow Metab"},{"key":"198_CR4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410380304","volume":"38","author":"MF Beal","year":"1995","unstructured":"Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357\u2013366","journal-title":"Ann Neurol"},{"key":"198_CR5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bmj.321.7253.70","volume":"321","author":"Berger","year":"2000","unstructured":"Berger, Abi (2000) Minocycline slows progress of Huntington\u2019s disease in mice. BMJ 321:70","journal-title":"BMJ"},{"key":"198_CR6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/01.WNL.0000049936.85487.7A","volume":"60","author":"RM Bonelli","year":"2003","unstructured":"Bonelli RM, Heuberger C, Reisecker F (2003) Minocycline for Huntington\u2019s Disease: An open label study. Neurology 60:883\u2013884","journal-title":"Neurology"},{"key":"198_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004850-200411000-00004","volume":"19","author":"RM Bonelli","year":"2004","unstructured":"Bonelli RM, H\u00f6dl AK, Hofmann P, Kapfhammer HP (2004) Neuroprotection in Huntington\u2019s disease: a 2-year study on minocycline. Intl Clin Psychopharmacol 19:337\u2013342","journal-title":"Intl Clin Psychopharmacol"},{"key":"198_CR8","first-page":"1202","volume":"60","author":"RR Brinkman","year":"1997","unstructured":"Brinkman RR, Mezei MM, Theilmann J, Almqvist E, Hayden MR (1997) The likelihood of being affected with Huntington\u2019s disease at a particular age, for a specific CAG size. Am J Hum Genet 60:1202\u20131210","journal-title":"Am J Hum Genet"},{"key":"198_CR9","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1073\/pnas.170280697","volume":"97","author":"J Carmichael","year":"2000","unstructured":"Carmichael J, Chatellier J, Woolfson A, Milstein C, Gersht AR, Rubinsztein DC (2000) Bacterial and Yeast Chaperones Reduce Both Aggregate Formation and Cell Death in Mammalian Cell Models of Huntington\u2019s Disease. Proc Natl Acad Sci U S A 97:9701\u20139705","journal-title":"Proc Natl Acad Sci U S A"},{"key":"198_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K","volume":"58","author":"SL Chan","year":"1999","unstructured":"Chan SL, Mattson MP (1999) Caspase and Calpain Substrates: Roles in Synaptic Plasticity and Cell Death. J Neurosci Res 58:167\u2013190","journal-title":"J Neurosci Res"},{"key":"198_CR11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797\u2013801","journal-title":"Nat Med"},{"key":"198_CR12","first-page":"195","volume":"181","author":"PGH Clarke","year":"1990","unstructured":"Clarke PGH (1990) Developmental Cell Death:morphological diversity and multiple mechanisms. Anat Embryol 181:195\u2013213","journal-title":"Anat Embryol"},{"key":"198_CR13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0197-4580(00)00148-2","volume":"21","author":"NR Cooper","year":"2000","unstructured":"Cooper NR, Kalaria RN, McGeer PL, Rogers J (2000) Key issues in Alzheimer\u2019s disease inflammation. Neurobiol Aging 21:451\u2013453","journal-title":"Neurobiol Aging"},{"key":"198_CR14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391\u2013397","journal-title":"Trends Neurosci"},{"key":"198_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004010000325","volume":"102","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, Puig B, Krupinski J, Carmona M, Blanco R (2001) Fas and Fas ligand expression Alzheimer\u2019s disease. Acta Neuropathol (Berl) 102:121\u2013131","journal-title":"Acta Neuropathol (Berl)"},{"key":"198_CR16","first-page":"123","volume":"23","author":"LS Forno","year":"1979","unstructured":"Forno LS, Norville RL (1979) Ultrastructure of the neostriatum in Huntington\u2019s and Parkinson\u2019s disease. Adv Neurol 23:123\u2013135","journal-title":"Adv Neurol"},{"key":"198_CR17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMra022366","volume":"348","author":"Friedlander","year":"2003","unstructured":"Friedlander, Robert M. (2003) Apoptosis and Caspases in Neurodegenerative Diseases. N Engl J Med 348:1365\u20131375","journal-title":"N Engl J Med"},{"key":"198_CR18","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/j.1460-2075.1995.tb07184.x","volume":"14","author":"Y Gu","year":"1995","unstructured":"Gu Y, Wu J, Faucheu C, Lalanne JL, Diu A, Livingston DH, Su MS (1995) Interleukin-1 beta converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J 14:1923\u20131931","journal-title":"EMBO J"},{"key":"198_CR19","volume-title":"Huntington\u2019s Disease","author":"PS Harper","year":"1996","unstructured":"Harper PS (1996) Huntington\u2019s Disease. 2nd ed. Saunders, London","edition":"2"},{"key":"198_CR20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(01)02681-6","volume":"909","author":"Y He","year":"2001","unstructured":"He Y, Appel S, Le W (2001) Minocycline inhibits microglial activation and protects nigral cells after 6-hydrozydopamine injection into mouse striatum. Brain Res 909:187\u2013193","journal-title":"Brain Res"},{"key":"198_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-5846(03)00021-6","volume":"27","author":"MA Hickey","year":"2003","unstructured":"Hickey MA, Chesselet MF (2003) Apoptosis in Huntington\u2019s Disease. Prog Neuropsychopharmacol Biol Psychiatry 27:255\u2013265","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"198_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li XJ, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"198_CR23","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosome. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"198_CR24","doi-asserted-by":"crossref","first-page":"14580","DOI":"10.1073\/pnas.93.25.14580","volume":"93","author":"P Kahlem","year":"1996","unstructured":"Kahlem P, Terre C, Green H, Djian P (1996) Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. Proc Natl Acad Sci U S A 93:14580\u201314585","journal-title":"Proc Natl Acad Sci U S A"},{"key":"198_CR25","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.M103946200","volume":"277","author":"KB Kegel","year":"2002","unstructured":"Kegel KB, Meloni AR, Yi Y, Kim YJ, Doyle D, Cuiffo BG, et al. (2002) Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem 277:7466\u20137476","journal-title":"J Biol Chem"},{"key":"198_CR26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.275.5303.1132","volume":"275","author":"RM Kluck","year":"1997","unstructured":"Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondrial: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132\u20131136","journal-title":"Science"},{"key":"198_CR27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1566-3124(01)06008-4","volume":"6","author":"VE Koliatsos","year":"2001","unstructured":"Koliatsos VE, Portera-Cailliau C, Schilling G, Borchelt DB, Becher MW, Ross CA (2001) Apoptosis in Huntington Disease and Animal Models. Adv Cell Aging Gerontol 6:205\u2013223","journal-title":"Adv Cell Aging Gerontol"},{"key":"198_CR28","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1038\/399a007","volume":"399","author":"JM Lee","year":"1999","unstructured":"Lee JM, Zipfel GJ, Choi DW (1999) The changing landscape of ischaemic brain injury mechanisms. Nature [Suppl 6738] 399:A7\u2013A14","journal-title":"Nature [Suppl 6738]"},{"key":"198_CR29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H Li","year":"1998","unstructured":"Li H, Zhu H, Xu CJ, Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491\u2013501","journal-title":"Cell"},{"key":"198_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.conb.2005.01.006","volume":"15","author":"M Mallat","year":"2005","unstructured":"Mallat M, Marin-Teva JL, Cheret C (2005) Phagocytosis in the developing CNS: more than clearing the corpses. Curr Opin Neurobiol 15:101\u2013107","journal-title":"Curr Opin Neurobiol"},{"key":"198_CR31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2174\/1381612805666230111212056","volume":"5","author":"EG McGeer","year":"1999","unstructured":"McGeer EG, McGeer PL (1999) Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharm Des 5:821\u2013 836","journal-title":"Curr Pharm Des"},{"key":"198_CR32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/47513","volume":"403","author":"T. Nakagawa","year":"2000","unstructured":"Nakagawa T., et al. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-\u03b2. Nature 403:98\u2013103","journal-title":"Nature"},{"key":"198_CR33","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/2.9.1475","volume":"2","author":"A Norremolle","year":"1993","unstructured":"Norremolle A, Riess O, Epplen JT, Fenger K, Hasholt L, Sorensen SA (1993) Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families. Hum Mol Genet 2:1475\u2013 1476","journal-title":"Hum Mol Genet"},{"key":"198_CR34","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/hmg\/9.14.2175","volume":"9","author":"LA Passani","year":"2000","unstructured":"Passani LA, Bedford MT, Faber PW, McGinnis KM, Sharp AH, Gusella JF, et al. (2000) Huntingtin\u2019s WW domain partners in Huntington\u2019s disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington\u2019s disease pathogenesis. Hum Mol Genet 9:2175\u20132182","journal-title":"Hum Mol Genet"},{"key":"198_CR35","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1073\/pnas.91.12.5355","volume":"91","author":"MF Perutz","year":"1994","unstructured":"Perutz MF, Johnson T, Suzuki M, Finch JT (1994) Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci U S A 91:5355\u20135358","journal-title":"Proc Natl Acad Sci U S A"},{"key":"198_CR36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.patbio.2003.06.004","volume":"52","author":"H Rangone","year":"2004","unstructured":"Rangone H, Humbert S, Saudou F (2004) Huntington\u2019s disease: how does huntingtin, an anti-apoptotic protein, become toxic? Pathol Biol 52:338\u2013342","journal-title":"Pathol Biol"},{"key":"198_CR37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0163-7258(95)02033-0","volume":"69","author":"NJ Rothwell","year":"1996","unstructured":"Rothwell NJ, Luheshi G, Toulmond S (1996) Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacol Ther 69:85\u201395","journal-title":"Pharmacol Ther"},{"key":"198_CR38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00427-7","volume":"64","author":"E Sapp","year":"1995","unstructured":"Sapp E, Ge P, Aizawa H, Bird E, Penney J, Young AB, et al. (1995) Evidence for a preferential loss of enkephalin immunoreactivity in the eternal globus pallidus in low grade Huntington\u2019s disease using high resolution image analysis. Neuroscience 64:397\u2013404","journal-title":"Neuroscience"},{"key":"198_CR39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin Acts in the Nucleus to induce Apoptosis but Death Does Not Correlate with the formation of intranuclear inclusions. Cell 95:55\u201366","journal-title":"Cell"},{"key":"198_CR40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s001090100223","volume":"79","author":"Sawa","year":"2001","unstructured":"Sawa, Akira (2001) Mechanisms for neuronal cell death and dysfunction in Huntington\u2019s disease: pathological cross-talk between the nucleus and the mitochondria? J Mol Med 79:375\u2013381","journal-title":"J Mol Med"},{"key":"198_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/MN:23:1:21","volume":"23","author":"S Sipione","year":"2001","unstructured":"Sipione S, Cattaneo E (2001) Modeling Huntington\u2019s Disease in Cells, Flies, and Mice. Mol Neurobiol 23:21\u201351","journal-title":"Mol Neurobiol"},{"key":"198_CR42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.144.2.281","volume":"144","author":"EA Slee","year":"1999","unstructured":"Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2,-3,-6,-7,-8, and \u201310 in a caspase-9-dependent manner. J Cell Biol 144:281\u2013292","journal-title":"J Cell Biol"},{"key":"198_CR43","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1073\/pnas.93.25.14486","volume":"93","author":"SM Srinivasula","year":"1996","unstructured":"Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES (1996) Molecular ordering of the Fas-apoptotic pathway: the Fas\/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3\/ICE-like cysteine proteases. Proc Natl Acad Sci USA 93:14486\u201314491","journal-title":"Proc Natl Acad Sci USA"},{"key":"198_CR44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1054-3589(08)61058-3","volume":"41","author":"NA Thornberry","year":"1997","unstructured":"Thornberry NA, Rosen A, Nicholson DW (1997) Control of Apoptosis by Proteases. Adv Pharmacol 41:155\u2013177","journal-title":"Adv Pharmacol"},{"key":"198_CR45","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.21-08-02580.2001","volume":"21","author":"T Tikka","year":"2001","unstructured":"Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia. J Neurosci 21:2580\u20132588","journal-title":"J Neurosci"},{"key":"198_CR46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-5728(99)00202-7","volume":"100","author":"O Touzani","year":"1999","unstructured":"Touzani O, Boutin H, Chuquet J, Rothwell N (1999) Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol 100:203\u2013215","journal-title":"J Neuroimmunol"},{"key":"198_CR47","first-page":"1","volume":"4","author":"M Vila","year":"2003","unstructured":"Vila M, Przedborski S (2003) Targeting Programmed Cell Death in Neurodegenerative Diseases. Neuroscience 4:1\u201311","journal-title":"Neuroscience"},{"key":"198_CR48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington\u2019s Disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"198_CR49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson Jr., EP (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"198_CR50","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jnnp.64.6.758","volume":"64","author":"I Vuillaume","year":"1998","unstructured":"Vuillaume I, Vermersch P, Destee A, Petit H, Sablonniere B (1998) Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington\u2019s disease. J. Neurol. Neurosurg. Psychiatry 64:758\u2013762","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"198_CR51","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","volume":"22","author":"CL Wellington","year":"2002","unstructured":"Wellington CL, Ellerby LM, Gutekunst CA, Rogers D, Warby S et al. (2002) Caspase Cleavage of Mutant Huntingtin Precedes Neurodegeneration in Huntington\u2019s Disease. J Neurosci 22:7862\u20137872","journal-title":"J Neurosci"},{"key":"198_CR52","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.275.5303.1129","volume":"275","author":"J Yang","year":"1997","unstructured":"Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129\u20131132","journal-title":"Science"},{"key":"198_CR53","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","volume":"95","author":"J Yrjanheikki","year":"1998","unstructured":"Yrjanheikki J, Kein\u00e4nen R, Pellikka M, H\u00f6kfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 95:15769 \u201315774","journal-title":"Proc Natl Acad Sci U S A"},{"key":"198_CR54","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","volume":"96","author":"J Yrjanheikki","year":"1999","unstructured":"Yrjanheikki J, Tikka T, Kein\u00e4nen R, Goldsteins G, Chan PH, Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96:13496\u201313500","journal-title":"Proc Natl Acad Sci U S A"},{"key":"198_CR55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat Genet 11:155\u2013163","journal-title":"Nat Genet"},{"key":"198_CR56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","volume":"417","author":"S Zhu","year":"2002","unstructured":"Zhu S, Stavrovskaya IG, Drozda M, et al. (2002) Minocycline inhibits cytochrome c release and delays progression of amytrophic lateral sclerosis in mice. Nature 417:74\u201378","journal-title":"Nature"},{"key":"198_CR57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, et al. (2001) Loss of huntingtin-mediated bDNF gene transcription in Huntington\u2019s disease. Science 293:493\u2013498","journal-title":"Science"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0198-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-006-0198-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0198-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T23:18:41Z","timestamp":1683587921000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-006-0198-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1007\/s00415-006-0198-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}